Loading…
Based on limited metadata, this FDA Warning Letter issued to PotNetwork Holdings, Inc. in March 2019 concerns drug products, though the specific violations cannot be determined as the subject line is unavailable. Without access to the full letter text, the exact nature of the regulatory concerns—whether related to manufacturing practices, marketing claims, product quality, or another drug-related violation—cannot be specified. The warning falls under FDA's drug regulatory authority, but the specific issuing office is not documented in the available metadata.